Stocktoria
3M CO MMM
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1946-01-14
3M CO financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $24.9B | $24.6B | $24.6B | $26.2B | $35.4B |
| R&D expense | — | $700.0M | $700.0M | $800.0M | $1.2B |
| SG&A expense | $4.0B | $4.2B | $19.2B | $7.2B | $7.2B |
| Operating income | $4.6B | $4.8B | -$10.7B | $4.4B | $7.4B |
| Interest expense | — | — | $942.0M | $462.0M | $488.0M |
| Income tax | $1.0B | $804.0M | -$2.9B | $188.0M | $1.3B |
| Net income | $3.2B | $4.2B | -$7.0B | $5.8B | $5.9B |
| EPS (diluted) | $6.00 | $7.55 | $-12.63 | $10.18 | $10.12 |
| Operating cash flow | $2.3B | $1.8B | $6.7B | $5.6B | $7.5B |
| Free cash flow | $1.4B | $638.0M | $5.1B | $3.8B | $5.9B |
| Inventory | $3.7B | $3.7B | $3.9B | $5.4B | $5.0B |
| Total assets | $37.7B | $39.9B | $50.6B | $46.5B | $47.1B |
| Total liabilities | $33.0B | $36.0B | $45.7B | $31.7B | $32.0B |
| Shareholders' equity | $4.7B | $3.9B | $4.9B | $14.8B | $15.1B |
Source: SEC EDGAR filings · CIK 0000066740 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.